Smoltek Announces SEK 32M Rights Issue
Smoltek's board has approved a SEK 32 million rights issue, aiming to strengthen its financial position and support future growth.
Sammanfattning
Smoltek has announced a SEK 32 million rights issue to bolster its financial resources, enabling further advancements in nanotechnology within the semiconductor and hydrogen sectors.
On May 27, 2025, the board of Smoltek, with authorization from the annual general meeting on May 14, 2025, decided to proceed with a rights issue of up to SEK 32 million. This strategic financial maneuver is poised to enhance Smoltek's capital structure, facilitating its ambitious growth plans in the nanotechnology domain.
The rights issue is meticulously documented in the Information Document, prepared in accordance with the EU Prospectus Regulation, ensuring transparency and compliance. The document is accessible on Smoltek's official website and the Spotlight Stock Market platform, where the company's shares are listed under the ticker SMOL.
Smoltek is renowned for pioneering disruptive nanotechnology solutions that address complex material challenges across industries. With a robust patent portfolio comprising over 110 patent applications, 96 of which are granted, Smoltek is well-positioned in the semiconductor and hydrogen sectors.
The timeline for the rights issue spans from June 9 to June 24, 2025, with trading of subscription rights occurring from June 9 to June 18, 2025, on the Spotlight Stock Market. The preliminary outcome will be announced on June 24, followed by the final outcome on June 26, 2025. Assuming the minimum subscription level is met, trading of paid subscribed shares is expected between weeks 27 and 28 of 2025.
Corpura Fondkommission AB and MAQS Advokatbyrå AB are serving as financial and legal advisors, respectively, ensuring the rights issue is executed seamlessly.
For investors, this rights issue presents an opportunity to participate in Smoltek's promising future. The company's focus on nanotechnology for the semiconductor and hydrogen markets positions it at the forefront of innovation and potential market expansion.
Given the strategic importance of this capital raising initiative, investors might consider holding their positions to benefit from Smoltek's growth trajectory. However, as with any investment, due diligence and consideration of market conditions are advised.
Källa
Sammanfattning
Den 27 maj 2025 beslutade Smolteks styrelse att genomföra en företrädesemission om högst 32 miljoner SEK, med stöd från årsstämman den 14 maj 2025. Fullständig information och villkor finns i Informationsdokumentet på Smolteks och Spotlight Stock Markets webbplatser. Emissionen följer EU:s Prospektförordning och har registrerats hos Finansinspektionen, men inte granskats av dem. Teckningsperioden är 9–24 juni 2025, med handel av teckningsrätter mellan 9–18 juni och preliminärt utfall offentliggörs 24 juni. Corpura Fondkommission AB och MAQS Advokatbyrå AB är rådgivare. Smoltek utvecklar produkter baserade på nanoteknologi inom halvledare och vätgas, och har en omfattande patentportfölj. Informationen i pressmeddelandet är inte ett erbjudande om att förvärva värdepapper och innehåller framåtriktade uttalanden som är prognoser. Informationen är avsedd för kvalificerade investerare och omfattas av legala restriktioner i vissa jurisdiktioner.
